Powerful Investing Tools, Made Simple.
Stay on top of Healthcare news using Beeken.io
Free Access
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
March 27, 2023 | Source: Zacks Investment Research
PHAR
Positive
Pharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric disease. The stock of the company is up about 33% following the same.